Eupraxia Pharmaceuticals Announces Pricing of Overnight Marketed Offering of $30 Million

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 -- Eupraxia Pharmaceuticals Inc. , a clinical-stage biotechnology company,...

Related Keywords

United Kingdom ,United States ,Canada ,Province Of Quebec ,Quebec ,Toronto ,Ontario ,British ,Danielle Egan ,Adam Peeler ,Scotia Plaza ,Company The ,Raymond James Ltd ,Eupraxia Pharmaceuticals Inc ,Toronto Stock Exchange ,British Columbia ,Raymond James ,Underwriting Agreement ,Toronto Stock ,United States Securities Act ,Regarding Forward Looking Statements ,Although Eupraxia ,Eupraxia Pharmaceuticals ,Markets ,